Yeji
FDA approvaloutcome: successconf 1.00

auvelity — FDA approval

$AXSM · Axsome Therapeutics, Inc.
Event date
April 30, 2026
37 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

openFDA SUPPL (EFFICACY) approval of AUVELITY — application NDA215430

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success
$JAZZvyxeos2026-01-27success

Recent insider activity· ±90 days

6 insiders · 0 buys · 6 sells
Sell10b5-1
2026-05-05
Jacobson Mark L.
Chief Operating Officer
233 @ $228.18$53K
Exercise10b5-1
2026-05-05
Jacobson Mark L.
Chief Operating Officer
233 @ $12.95$3K
Exercise10b5-1
2026-05-04
Jacobson Mark L.
Chief Operating Officer
4,517 @ $12.95$58K
Sell10b5-1
2026-05-04
Jacobson Mark L.
Chief Operating Officer
4,517 @ $227.94$1.03M
Exercise10b5-1
2026-04-22
Maizel Ari
Chief Commercial Officer
7,500 @ $70.73$530K
Sell10b5-1
2026-04-22
Maizel Ari
Chief Commercial Officer
7,500 @ $182.42$1.37M
Grant
2026-04-21
Jacobson Mark L.
Chief Operating Officer
8,669 @
Grant
2026-04-21
Maizel Ari
Chief Commercial Officer
7,224 @
Grant
2026-04-21
TABUTEAU HERRIOT
Chief Executive Officer
24,081 @
Grant
2026-04-21
Murdock Hunter R.
General Counsel
7,224 @
Grant
2026-04-21
Pizzie Nick
Chief Financial Officer
8,188 @
Grant
2026-02-26
TABUTEAU HERRIOT
Chief Executive Officer
54,623 @
Grant
2026-02-26
Maizel Ari
Chief Commercial Officer
16,385 @
Grant
2026-02-26
Jacobson Mark L.
Chief Operating Officer
19,663 @
Exercise10b5-1
2026-02-26
Jacobson Mark L.
Chief Operating Officer
35,378 @ $2.85$101K
Sell10b5-1
2026-02-26
Jacobson Mark L.
Chief Operating Officer
35,378 @ $161.88$5.73M
Grant
2026-02-26
Murdock Hunter R.
General Counsel
16,385 @
Grant
2026-02-26
Pizzie Nick
Chief Financial Officer
18,570 @
Sell10b5-1
2026-02-26
Coleman Mark
Director
25,000 @ $161.11$4.03M
Exercise
2026-02-23
Coleman Mark
Director
6,250 @ $4.95$31K
Exercise
2026-02-20
Coleman Mark
Director
12,485 @ $4.95$62K
Exercise
2026-02-10
Coleman Mark
Director
5,193 @ $8.02$42K
Sell10b5-1
2026-02-02
TABUTEAU HERRIOT
Chief Executive Officer
32,410 @ $185.60$6.02M
Exercise10b5-1
2026-02-02
TABUTEAU HERRIOT
Chief Executive Officer
32,410 @ $8.02$260K